Reuters logo
BRIEF-Voyager Therapeutics reports Q1 GAAP loss per share $0.65
May 9, 2017 / 9:43 PM / in 5 months

BRIEF-Voyager Therapeutics reports Q1 GAAP loss per share $0.65

May 9 (Reuters) - Voyager Therapeutics Inc

* Voyager Therapeutics reports first quarter 2017 financial results and corporate highlights

* Q1 GAAP loss per share $0.65

* Q1 earnings per share view $-0.53 -- Thomson Reuters I/B/E/S

* Voyager Therapeutics Inc - Collaboration revenues of $1.5 million for Q1 of 2017 compared to collaboration revenues of $4.8 million for Q1 of 2016. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below